Cyclooxygenase-1 (COX-1) and COX-1 Inhibitors in Cancer: A Review of Oncology and Medicinal Chemistry Literature (original) (raw)
Characterization of cyclooxygenase-2 (COX-2) during tumorigenesis in human epithelial cancers: evidence for potential clinical utility of COX-2 inhibitors in epithelial cancers
Nasir Khan
Prostaglandins, Leukotrienes and Essential Fatty Acids, 2002
View PDFchevron_right
The role of cyclooxygenase-2 (COX-2) in breast cancer, and implications of COX-2 inhibition
Gurpreet Singh-ranger
European Journal of Surgical Oncology (EJSO), 2002
View PDFchevron_right
Increased cyclooxygenase-2 (cox-2) expression and activity in a murine model of metastatic breast cancer
Amy Fulton
International Journal of Cancer, 2001
View PDFchevron_right
Pathogenic Role of Cyclooxygenase-2 in Cancer
Anantha Krishna
Journal of health science, 2010
View PDFchevron_right
Cyclooxygenases in cancer: progress and perspective
Shan Zha
Cancer Letters, 2004
View PDFchevron_right
International Journal of Research in Pharmacy and Chemistry Role of CYCLOOXYGENASE-2 in Cancer
Chetan Rajendra Sonawane
View PDFchevron_right
Cyclooxygenase-2 (COX-2) inhibitors sensitize tumor cells specifically to death receptor-induced apoptosis independently of COX-2 inhibition
Reiner Jänicke
Oncogene, 2003
View PDFchevron_right
Differential expression and regulation of cyclooxygenase-1 and -2 in two human breast cancer cell lines
Xin-Hua Liu
Cancer research, 1996
View PDFchevron_right
Cyclooxygenase‐2 in cancer: A review
Masoud Najafi, Bagher Farhood
View PDFchevron_right
Selective cyclooxygenase (COX)-1 or COX-2 inhibitors control metastatic disease in a murine model of breast cancer
Amy Fulton
Cancer research, 2002
View PDFchevron_right
Targeting COX-2 expression by natural compounds: A promising alternative strategy to synthetic COX-2 inhibitors for cancer chemoprevention and therapy
Mario Dicato
Biochemical Pharmacology, 2010
View PDFchevron_right
Selective Cyclooxygenase (COX)-1 or COX2 Inhibitors Control Metastatic Disease in a Murine Model of Breast Cancer1
Amy Fulton
2002
View PDFchevron_right
Current concepts in cyclooxygenase inhibition in breast cancer
Gurpreet Singh-ranger
Journal of Clinical Pharmacy and Therapeutics, 2002
View PDFchevron_right
Cancer Prevention: A New Era beyond Cyclooxygenase-2
Khosrow Kashfi
Journal of Pharmacology and Experimental Therapeutics, 2005
View PDFchevron_right
The Role of Cyclooxygenase-2 in Cell Proliferation and Cell Death in Human Malignancies
Claudia Cerella
International Journal of Cell Biology, 2010
View PDFchevron_right
The role of cyclooxygenase-2 in prostate cancer
Xin-Hua Liu
Urology, 2001
View PDFchevron_right
Cyclooxygenase2 (COX2) immunoreactivity in human endometrial carcinoma and precursor lesions: the potential use of COX2 inhibitors in cancer chemoprevention and therapy
Ardeshir Hakam
2000
View PDFchevron_right
Cyclooxygenase-2 (COX-2): a molecular target in prostate cancer
Paula Fonseca
Clinical and Translational Oncology, 2007
View PDFchevron_right
Cyclooxygenase-1 and -2: Molecular Targets for Cervical Neoplasia
Yong Song
Journal of Cancer Prevention, 2013
View PDFchevron_right
Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors
Jaime Masferrer, Kathleen Leahy
Cancer research, 2000
View PDFchevron_right
2-induced breast cancer progression -dependent angiogenic switch in cyclooxygenase 2 From the Cover: Role of prostaglandin E
timothy hla
2006
View PDFchevron_right
COX-2 inhibitors in NSCLC: never-ending story or misplaced?
Alex Martinez Marti
Translational Lung Cancer Research
View PDFchevron_right
Cyclooxygenase inhibitors – current status and future prospects
Gerd Dannhardt
European Journal of Medicinal Chemistry, 2001
View PDFchevron_right
Elder DJE, Halton DE, Hague A, Paraskeva CInduction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression. Clin Cancer Res 3: 1679-1683
Angela Hague
Clinical Cancer Research
View PDFchevron_right
Cyclooxygenase-2 and Gastrointestinal Cancer
Jason Mann
The Cancer Journal, 2004
View PDFchevron_right
Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression
timothy hla
Proceedings of the National Academy of Sciences, 2004
View PDFchevron_right
Correlation between cyclooxygenase-2 and tumor angiogenesis in non-small cell lung cancer
Hyung-Seok Kim
Lung Cancer, 2003
View PDFchevron_right
Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression
Angela Hague
Clinical cancer research : an official journal of the American Association for Cancer Research, 1997
View PDFchevron_right
Cyclooxygenase and Cancer: Fundamental Molecular Investigations
Mauro Coluccia
International Journal of Molecular Sciences
View PDFchevron_right
Cyclooxygenase-2 is up-regulated in proliferative inflammatory atrophy of the prostate, but not in prostate carcinoma
Shan Zha
Cancer research, 2001
View PDFchevron_right
Cyclooxygenase-2 modulates cellular growth and promotes tumorigenesis
timothy hla
Journal of Cellular and Molecular Medicine, 2003
View PDFchevron_right
Cyclooxygenase-1 is up-regulated in cervical carcinomas: autocrine/paracrine regulation of cyclooxygenase-2, prostaglandin e receptors, and angiogenic factors by cyclooxygenase-1
Henry Jabbour
Cancer research, 2002
View PDFchevron_right
Clinical implications of expression of cyclooxygenase-2 related to angiogenesis in ovarian cancer
Syed Alam
Oncology Reports
View PDFchevron_right
Cyclooxygenases in hepatocellular carcinoma
Melchiorre Cervello
World Journal of Gastroenterology, 2006
View PDFchevron_right
Cyclooxygenase-1 is overexpressed and promotes angiogenic growth factor production in ovarian cancer
Sanjoy Das
Cancer research, 2003
View PDFchevron_right